SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $2,107,306,424 |
| Positions | 16 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| REVOLUTION MEDICINES INC | RVMD | COM | $1,423,531,573 | 7,601,087 |
| PARABILIS MEDICINES INC | PBLS | COM | $127,631,127 | 4,663,176 |
| RELAY THERAPEUTICS INC | RLAY | COM | $126,788,427 | 6,776,506 |
| TYRA BIOSCIENCES INC | TYRA | COM | $113,501,505 | 3,553,585 |
| ALUMIS INC | ALMS | COM | $99,643,684 | 3,540,998 |
| ORIC PHARMACEUTICALS INC | ORIC | COM | $77,571,359 | 7,162,637 |
| KYMERA THERAPEUTICS INC | KYMR | COM | $31,981,004 | 278,896 |
| ZYMEWORKS INC | ZYME | COM | $29,118,548 | 1,113,946 |
| MONTE ROSA THERAPEUTICS INC | GLUE | COM | $18,419,903 | 761,153 |
| CYTOMX THERAPEUTICS INC. | CTMX | COM | $16,687,245 | 4,449,932 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.